Clinical Trial Update: Paclitaxol Every 2 Week Versus Paclitaxol Every 1 Week in the Adjuvant Treatment of Breast Cancer [NA]

View source ↗

Summary

This clinical trial compares paclitaxel dosing frequency (every two weeks vs every week) in adjuvant treatment for breast cancer; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Epirubicin (epirubicin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Taizhou Hospital | Conditions: Breast Cancer, Paclitaxel | NA | Status: UNKNOWN